Locations:
Search
Common cancer therapy increases serious risks in murine models
Treatment may be a lifesaving option for patients with relapsed or refractory disease
Study suggests new approach is safer than standard treatment and may help prevent graft-versus-host disease
Understudied Src Family Kinase may serve as a potential therapeutic target
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Sarcopenia and sarcopenic obesity appear to increase risk of early chemotherapy termination
Modification of traditional staging factors associated with survival in high-risk disease
Virtual clinic supports oncologists by educating patients and making treatment recommendations
Molecular tumor profiling is available to patients
Is resection possible without major aortic bleeding?
Hyperthermia, neoadjuvant chemoradiation and reconstruction hold promise of long-term survival
Advertisement
Advertisement